In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

Evidence suggests that the non-psychotropic phytocannabinoid cannabidiol (CBD) has anticancer activity on different cell lines and in animal models. The DNA-damaging drug epirubicin (EPI) is widely used for the treatment of malignant tumours. In this study we examined the effectiveness of CBD admini...

Full description

Saved in:
Bibliographic Details
Main Authors: Margarita Zhelyazkova, Nadya Hristova-Avakumova, Lozan Todorov, Georgi Momekov
Format: article
Language:EN
Published: Taylor & Francis Group 2021
Subjects:
antagonism
cannabidiol
combination chemotherapy
epirubicin
free radicals
oxidative molecular damage
Biotechnology
TP248.13-248.65
Online Access:https://doaj.org/article/561a735bda53473f927a09373311a1bb
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items